ARS Pharmaceuticals (SPRY) Operating expenses

annual operating expenses:

$91.25M+$23.70M(+35.09%)
December 31, 2024

Summary

  • As of today (July 4, 2025), SPRY annual total operating expenses is $91.25 million, with the most recent change of +$23.70 million (+35.09%) on December 31, 2024.
  • During the last 3 years, SPRY annual operating expenses has risen by +$66.30 million (+265.60%).
  • SPRY annual operating expenses is now at all-time high.

Performance

SPRY Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYincome statement metrics

quarterly operating expenses:

$44.06M+$5.54M(+14.37%)
March 31, 2025

Summary

  • As of today (July 4, 2025), SPRY quarterly total operating expenses is $44.06 million, with the most recent change of +$5.54 million (+14.37%) on March 31, 2025.
  • Over the past year, SPRY quarterly operating expenses has increased by +$30.86 million (+233.96%).
  • SPRY quarterly operating expenses is now at all-time high.

Performance

SPRY quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

SPRY Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+35.1%+234.0%
3 y3 years+265.6%+467.6%
5 y5 years+398.6%-

SPRY Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+265.6%at high+547.1%
5 y5-yearat high+398.6%at high+547.1%
alltimeall timeat high+398.6%at high+547.1%

SPRY Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$44.06M(+14.4%)
Dec 2024
$91.25M(+35.1%)
$38.52M(+62.5%)
Sep 2024
-
$23.70M(+49.6%)
Jun 2024
-
$15.84M(+20.1%)
Mar 2024
-
$13.19M(+29.0%)
Dec 2023
$67.55M
$10.23M(-43.1%)
Sep 2023
-
$17.98M(-12.8%)
DateAnnualQuarterly
Jun 2023
-
$20.61M(+10.0%)
Mar 2023
-
$18.73M(+21.3%)
Dec 2022
$36.83M(+47.6%)
$15.44M(+126.5%)
Sep 2022
-
$6.82M(+0.2%)
Jun 2022
-
$6.81M(-12.3%)
Mar 2022
-
$7.76M
Dec 2021
$24.96M(+36.4%)
-
Dec 2020
$18.30M
-

FAQ

  • What is ARS Pharmaceuticals annual total operating expenses?
  • What is the all time high annual operating expenses for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual operating expenses year-on-year change?
  • What is ARS Pharmaceuticals quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly operating expenses year-on-year change?

What is ARS Pharmaceuticals annual total operating expenses?

The current annual operating expenses of SPRY is $91.25M

What is the all time high annual operating expenses for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual total operating expenses is $91.25M

What is ARS Pharmaceuticals annual operating expenses year-on-year change?

Over the past year, SPRY annual total operating expenses has changed by +$23.70M (+35.09%)

What is ARS Pharmaceuticals quarterly total operating expenses?

The current quarterly operating expenses of SPRY is $44.06M

What is the all time high quarterly operating expenses for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly total operating expenses is $44.06M

What is ARS Pharmaceuticals quarterly operating expenses year-on-year change?

Over the past year, SPRY quarterly total operating expenses has changed by +$30.86M (+233.96%)
On this page